TTNP Titan Pharmaceuticals, Inc. Stock Quote

TTNP [NASD]

Index	-	P/E	-	EPS (ttm)	-7.40	Insider Own	5.08%	Shs Outstand	9.86M	Perf Week	-17.73%
Market Cap	34.00M	Forward P/E	-	EPS next Y	-3.51	Insider Trans	0.00%	Shs Float	5.29M	Perf Month	-2.62%
Income	-19.10M	PEG	-	EPS next Q	-1.33	Inst Own	3.60%	Short Float	24.86%	Perf Quarter	-39.49%
Sales	5.00M	P/S	6.80	EPS this Y	7.90%	Inst Trans	52.40%	Short Ratio	0.71	Perf Half Y	-53.51%
Book/sh	-0.27	P/B	-	EPS next Y	43.90%	ROA	-188.30%	Target Price	-	Perf Year	-45.48%
Cash/sh	0.40	P/C	8.29	EPS next 5Y	-	ROE	-	52W Range	2.82 - 16.35	Perf YTD	1.52%
Dividend	-	P/FCF	-	EPS past 5Y	3.20%	ROI	-307.70%	52W High	-79.75%	Beta	1.06
Dividend %	-	Quick Ratio	0.90	Sales past 5Y	-0.20%	Gross Margin	67.30%	52W Low	17.42%	ATR	0.38
Employees	21	Current Ratio	1.10	Sales Q/Q	22.20%	Oper. Margin	-	RSI (14)	44.56	Volatility	10.43% 10.26%
Optionable	Yes	Debt/Eq	-	EPS Q/Q	72.10%	Profit Margin	-	Rel Volume	0.62	Prev Close	3.34
Shortable	Yes	LT Debt/Eq	-	Earnings	-	Payout	-	Avg Volume	1.86M	Price	3.31
Recom	2.00	SMA20	-9.17%	SMA50	-3.11%	SMA200	-45.25%	Volume	1,111,592	Change	-0.86%

Jun-26-19

Initiated

Maxim Group

Buy

Nov-10-17

Downgrade

ROTH Capital

Buy → Neutral

Feb-01-21 07:30AM	Positive Early Study Results Help Pave Wave for Titan Pharmaceuticals to Move Forward with its JT-09 ProNeura® Development Program PR Newswire +9.81%
Jan-15-21 09:15AM	Titan Pharmaceuticals Announces Pricing of $9.7 Million Registered Direct Offering PR Newswire -9.43%
Dec-16-20 08:00AM	Titan Pharmaceuticals Regains Compliance with Nasdaq Listing Requirements PR Newswire -6.05%
Dec-01-20 04:56AM	TTNP: Coverage Discontinued Zacks Small Cap Research -26.27%
Nov-30-20 12:50PM	Titan Pharmaceuticals Announces Reverse Stock Split PR Newswire
Nov-16-20 08:45AM	Titan Pharmaceuticals Reports Third Quarter 2020 Financial Results PR Newswire
Nov-02-20 08:00AM	Titan Pharmaceuticals Completes Debt Settlement With Molteni And Horizon & Acquisiton Of JT Pharma's Kappa Opioid Agonist Peptide, JT-09 PR Newswire -22.31%
Oct-30-20 08:14AM	7 Penny Stocks to Watch in November InvestorPlace
Oct-28-20 03:00PM	Titan Pharmaceuticals Announces Pricing of $8.0 Million Underwritten Public Offering PR Newswire +29.88%
08:00AM	Titan Pharmaceuticals Enters Into Definitive Agreement To Acquire JT Pharma's Kappa Opioid Agonist Peptide, JT-09 PR Newswire
Oct-26-20 06:30AM	Titan Pharmaceuticals Announces Debt Settlement Agreement with Molteni and Horizon PR Newswire +9.11%
Oct-15-20 08:00AM	Titan Pharmaceuticals Provides a Strategic & Corporate Update PR Newswire -7.20%
Sep-24-20 09:00AM	Titan Pharmaceuticals Announces Pricing of $2.7 Million Registered Direct Offering PR Newswire -12.66%
Sep-18-20 04:45PM	Titan Pharmaceuticals' Stockholders Approve Proposal To Amend Its Certificate Of Incorporation PR Newswire
Sep-16-20 01:05PM	Here's What We Think About Titan Pharmaceuticals' (NASDAQ:TTNP) CEO Pay Simply Wall St.
Sep-15-20 08:30AM	Titan's Probuphine® Commercialization Partner, Molteni, Enters Into Exclusive European Distribution Agreement With Accord Healthcare PR Newswire +16.47%
Sep-14-20 08:30AM	Titan Pharmaceuticals Provides Update To Stockholders On Proposal To Amend Its Certificate Of Incorporation PR Newswire -8.43%
Aug-26-20 05:45AM	TTNP: Indegene to Advance Probuphine Commercialization Zacks Small Cap Research
Aug-14-20 08:45AM	Titan Pharmaceuticals Reports Second Quarter 2020 Financial Results PR Newswire -5.76%
Aug-10-20 04:30PM	Titan Pharmaceuticals To Report Second Quarter 2020 Financial Results On August 14, 2020 PR Newswire
Jul-08-20 08:00AM	Titan Pharmaceuticals Urges Stockholders to Vote "FOR" Proposal to Amend Its Certificate of Incorporation PR Newswire
Jun-24-20 08:00AM	Titan Pharmaceuticals And Indegene Enter Into Probuphine® Co-Promotion Partnership PR Newswire +24.03%
Jun-16-20 08:00AM	Titan Pharmaceuticals Launches Virtual REMS Training For Probuphine Health Care Providers PR Newswire
Jun-01-20 05:20AM	TTNP: First Quarter 2020 Financial and Operational Results Zacks Small Cap Research
May-15-20 08:45AM	Titan Pharmaceuticals Reports First Quarter 2020 Financial Results PR Newswire -19.14%
May-11-20 04:03PM	Titan Pharmaceuticals To Report First Quarter 2020 Financial Results On May 15, 2020 PR Newswire
Apr-09-20 06:15AM	TTNP: Full Year 2019 Financial and Operational Results Zacks Small Cap Research
Apr-02-20 09:47PM	Edited Transcript of TTNP earnings conference call or presentation 30-Mar-20 8:30pm GMT Thomson Reuters StreetEvents
Mar-31-20 12:43PM	Penny Stocks to Buy Using Technical Analysis for April 2020 Investopedia -14.65%
Mar-30-20 04:03PM	Titan Pharmaceuticals Reports Fourth Quarter And Full Year 2019 Financial Results PR Newswire +9.20%
02:30PM	Titan Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE
Mar-26-20 08:00AM	Titan Pharmaceuticals To Report Fourth Quarter And Full Year 2019 Financial Results On March 30, 2020 PR Newswire
Mar-05-20 09:00AM	Titan Pharmaceuticals Receives $5.9 Million From Exercise Of Warrants PR Newswire +12.57%
Feb-18-20 08:55AM	Did Changing Sentiment Drive Titan Pharmaceuticals's (NASDAQ:TTNP) Share Price Down A Disastrous 99%? Simply Wall St.
Jan-13-20 08:00AM	Titan Pharmaceuticals Announces Addition Of Probuphine® To Federal Supply Schedule PR Newswire
Jan-07-20 09:15AM	Titan Pharmaceuticals Announces Pricing of $2.2 Million Registered Direct Offering PR Newswire -19.83%
Dec-30-19 08:00AM	Titan Pharmaceuticals Appoints Dr. Kate DeVarney To Its Board Of Directors PR Newswire +22.72%
Dec-17-19 10:30AM	Should You Worry About Titan Pharmaceuticals, Inc.'s (NASDAQ:TTNP) CEO Pay? Simply Wall St.
Dec-04-19 01:22PM	Edited Transcript of TTNP earnings conference call or presentation 14-Nov-19 9:30pm GMT Thomson Reuters StreetEvents
Dec-03-19 09:00AM	Titan Pharmaceuticals To Present At The First Annual BioTuesdays Pre-JPM Virtual Conference PR Newswire +20.43%
Nov-25-19 05:15AM	TTNP: Waiting for Revenue Turn Zacks Small Cap Research
Nov-14-19 04:03PM	Titan Pharmaceuticals Reports Third Quarter 2019 Financial Results PR Newswire +12.04%
Nov-07-19 04:30PM	Titan Pharmaceuticals To Release Third Quarter 2019 Financial Results On November 14 - Conference Call To Follow PR Newswire
Oct-22-19 08:00AM	Titan Pharmaceuticals To Present Two Posters On Probuphine® At The 10th American Conference On Pharmacometrics PR Newswire
Oct-18-19 10:23AM	These 24 Bay Area drug and diagnostics companies quietly raised nearly $3B this year American City Business Journals +5.11%
Oct-16-19 09:20AM	Titan Pharmaceuticals Announces Pricing Of $9.0 Million Underwritten Public Offering PR Newswire -51.02%
Oct-01-19 08:00AM	Titan Pharmaceuticals and Crossroads of Southern Nevada Announce Probuphine® Availability at Crossroads Rehabilitation Facilities PR Newswire
Sep-18-19 08:00AM	Titan Receives Approval For Second Year Of NIDA Grant Funding For Development Of A Nalmefene Implant PR Newswire +20.91%
Aug-30-19 08:01PM	Edited Transcript of TTNP earnings conference call or presentation 14-Aug-19 8:30pm GMT Thomson Reuters StreetEvents
Aug-23-19 11:30AM	TTNP: Long on Opportunity, Short on Capital Zacks Small Cap Research -6.17%
Aug-17-19 09:59AM	Some Titan Pharmaceuticals (NASDAQ:TTNP) Shareholders Have Copped A 99% Share Price Wipe Out Simply Wall St.
Aug-16-19 07:33AM	The Daily Biotech Pulse: Roche Snags Double Nod For Personalized Cancer Drug, Bellicum Offering, Nabriva Braces For Contepo Resubmission Benzinga +7.51%
Aug-14-19 04:03PM	Titan Pharmaceuticals Reports Second Quarter 2019 Financial Results PR Newswire
07:32AM	Q2 Earnings Preview For Titan Pharmaceuticals Benzinga
Aug-09-19 05:00PM	Titan Pharmaceuticals To Release Second Quarter 2019 Financial Results On August 14 - Conference Call To Follow PR Newswire
Aug-07-19 09:15AM	Titan Pharmaceuticals Announces Pricing Of $2.1 Million Registered Direct Offering PR Newswire -27.38%
Jul-09-19 09:00AM	Titan Pharmaceuticals Expands Patient Access To Probuphine® Via Specialty Product Distribution Agreement With CVS Caremark PR Newswire
Jul-03-19 10:54AM	What Does Titan Pharmaceuticals, Inc.'s (NASDAQ:TTNP) Balance Sheet Tell Us About It? Simply Wall St.
Jun-26-19 09:10AM	Titan Pharmaceuticals And Molteni Receive European Regulatory Approval For Probuphine PR Newswire -5.56%
Jun-04-19 07:00AM	Titan Pharmaceuticals Partners With Southside To Further Expand Specialty Pharmacy Network For Probuphine® PR Newswire +11.61%
May-29-19 02:15PM	TTNP: A+ Partnerships: AllianceRx, AppianRx & Accredo Zacks Small Cap Research
May-23-19 08:10AM	Edited Transcript of TTNP earnings conference call or presentation 15-May-19 8:30pm GMT Thomson Reuters StreetEvents
May-15-19 04:08PM	Titan Pharmaceuticals: 1Q Earnings Snapshot Associated Press
04:03PM	Titan Pharmaceuticals Reports First Quarter 2019 Financial Results PR Newswire
May-13-19 07:00AM	Titan Pharmaceuticals Further Expands Patient Access To Probuphine® Via Product Purchase And Supply Agreement With Express Scripts' Specialty Pharmacy, Accredo® PR Newswire
May-08-19 08:00PM	Titan Pharmaceuticals To Release First Quarter 2019 Financial Results On May 15 - Conference Call To Follow PR Newswire
May-06-19 03:12PM	Edited Transcript of TTNP earnings conference call or presentation 2-Apr-19 12:30pm GMT Thomson Reuters StreetEvents
Apr-29-19 07:00AM	Titan Pharmaceuticals And Molteni Announce Positive EU CHMP Opinion For Probuphine® PR Newswire
Apr-12-19 05:00PM	Knight Therapeutics: Use of PROBUPHINE for Opioid Disorder Gains Momentum Across Canada; Subdermal Implant Now in Use from Coast to Coast GlobeNewswire
Apr-11-19 09:45AM	TTNP: EMA Approval of Probuphine Expected 2Q:19 Zacks Small Cap Research
Apr-02-19 01:06AM	/C O R R E C T I O N -- Titan Pharmaceuticals, Inc./ PR Newswire
Apr-01-19 05:07PM	Titan Pharmaceuticals: 4Q Earnings Snapshot Associated Press
04:30PM	Titan Pharmaceuticals Reports Fourth Quarter And Full Year 2018 Financial Results PR Newswire
Mar-28-19 07:00AM	Titan Pharmaceuticals Partners With AppianRx To Provide Comprehensive Probuphine® Patient Support Services PR Newswire
Mar-26-19 07:00AM	Titan Pharmaceuticals To Report Fourth Quarter And Full Year 2018 Financial Results On April 1, 2019 PR Newswire
Feb-25-19 02:20PM	4 Healthcare Stocks Looking To Kick Off A Strong Week ACCESSWIRE +27.78%
07:00AM	Titan Pharmaceuticals Partners With AllianceRx Walgreens Prime Specialty Pharmacy To Expand Patient Access To Probuphine® PR Newswire
Feb-08-19 09:30AM	TTNP: Shipments Spike in 2H:18 Zacks Small Cap Research
Feb-01-19 02:31PM	4 Healthcare Stocks Looking To Start February Off Strong ACCESSWIRE +34.15%
12:01PM	How Many Insiders Bought Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) Shares? Simply Wall St.
11:46AM	Why Titan Pharmaceuticals Stock Is Skyrocketing Today InvestorPlace
11:10AM	Pipeline Update, Review and Progress Titan Pharmaceuticals, Inc. ACCESSWIRE
Jan-31-19 06:36PM	Titan Pharmaceuticals Reports Positive Initial Results Of Probuphine® Relaunch PR Newswire
Jan-24-19 07:00AM	Titan Pharmaceuticals Announces Reverse Stock Split PR Newswire
Dec-21-18 12:54PM	Edited Transcript of TTNP earnings conference call or presentation 14-Nov-18 9:15pm GMT Thomson Reuters StreetEvents -8.56%
Dec-10-18 10:35AM	Alternatives to Watch ACCESSWIRE
Nov-21-18 07:25AM	Factors of Influence in 2018, Key Indicators and Opportunity within Atlantic American, Titan Medical, Adial Pharmaceuticals, Aptinyx, Sotherly Hotels, and Titan Pharmaceuticals New Research Emphasizes Economic Growth GlobeNewswire
Nov-20-18 11:15AM	TTNP: New CCO Implementing Targeted Strategy Zacks Small Cap Research
Nov-14-18 04:38PM	Titan Pharmaceuticals: 3Q Earnings Snapshot Associated Press +10.23%
04:01PM	Titan Pharmaceuticals Reports Third Quarter 2018 Financial Results PR Newswire
Nov-08-18 07:00AM	Titan Pharmaceuticals Schedules Conference Call To Review Third Quarter 2018 Financial Results PR Newswire
Nov-07-18 09:30AM	Biotech Stocks and the Midterm Elections ACCESSWIRE
Nov-05-18 08:55AM	3 Stocks To Watch As Healthcare Market Evolves ACCESSWIRE +18.74%
07:00AM	Todays Research Reports on Stocks to Watch: Conatus Pharmaceuticals and Titan Pharmaceuticals ACCESSWIRE
Nov-02-18 10:30AM	Surge In Healthcare Growth Sees Rally In These 3 Stocks On Friday ACCESSWIRE +22.62%
Oct-30-18 09:45AM	3 Healthcare Stocks that Could Move on Industry Growth ACCESSWIRE -5.92%
Oct-29-18 08:00AM	Knight Therapeutics Announces the Canadian launch of PROBUPHINE for Opioid Use Disorder GlobeNewswire
Oct-23-18 02:40PM	These 3 Stocks Are Moving Higher This Month ACCESSWIRE +36.36%
Oct-22-18 08:00AM	Today's Research Reports on Trending Tickers: Titan Pharmaceuticals and Amarin Corporation ACCESSWIRE -6.98%
Oct-15-18 08:15AM	Titan Pharmaceuticals Moving Forward with its ProNeura Technology, Analysts Review ACCESSWIRE +11.88%

Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases. It develops products based on ProNeura, a proprietary long-term drug delivery platform that focuses primarily on the treatment for chronic diseases. The company also develops ProNeura-Ropinirole, an implant to provide delivery of ropinirole, a dopamine agonist for the treatment of Parkinson's disease; and triiodothyronine, an implant for the treatment of hypothyroidism. Titan Pharmaceuticals, Inc. was incorporated in 1992 and is based in South San Francisco, California.

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience